Teva to Present at the Barclays Global Annual Healthcare Conference
March 13 2017 - 11:00AM
Business Wire
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will
host a live audio webcast at the Barclays Global Healthcare
Conference in Miami, Florida.
When:
Wednesday, March 15, 2017 at 9:00 AM ET
Who:
Eyal Desheh, Group EVP & CFO, Mike Derkacz, SVP, Head of Global
CNS, Teva Pharmaceutical Industries Ltd.
Where:
http://ir.tevapharm.com
How:
Live over the Internet – log on to the Web
at the address above and register for the event (approximately 10
minutes before). An archive of the webcast will be available on
Teva’s Website at http://ir.tevapharm.com.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a
leading global pharmaceutical company that delivers high-quality,
patient-centric healthcare solutions used by approximately 200
million patients in 100 markets every day. Headquartered in Israel,
Teva is the world’s largest generic medicines producer, leveraging
its portfolio of more than 1,800 molecules to produce a wide range
of generic products in nearly every therapeutic area. In specialty
medicines, Teva has the world-leading innovative treatment for
multiple sclerosis as well as late-stage development programs for
other disorders of the central nervous system, including movement
disorders, migraine, pain and neurodegenerative conditions, as well
as a broad portfolio of respiratory products. Teva is leveraging
its generics and specialty capabilities in order to seek new ways
of addressing unmet patient needs by combining drug development
with devices, services and technologies. Teva's net revenues in
2016 were $21.9 billion. For more information, visit
www.tevapharm.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170313005745/en/
Teva Pharmaceutical Industries Ltd.IR Contacts:United
StatesKevin C. Mannix, 215-591-8912orRan Meir,
215-591-3033orIsraelTomer Amitai, 972 (3) 926-7656orPR
Contacts:IsraelIris Beck Codner, 972 (3) 926-7246orUnited
StatesDenise Bradley, 215-591-8974
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Apr 2023 to Apr 2024